drug < drugs < drury

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]

Ident.	Authors (with country if any)	Title
000079 (1993)	Liviana M. Calzavara [Canada] ; Randall A. Coates [Canada] ; Janet M. Raboud [Canada] ; Vernon T. Farewell [Canada] ; Stanley E. Read [Canada] ; Frances A. Shepherd [Canada] ; Mary M. Fanning [Canada] ; Douglas Macfadden [Canada]	Ongoing high-risk sexual behaviors in relation to recreational drug use in sexual encounters Analysis of 5 years of data from the Toronto sexual contact study
000201 (2008)	Ling-Hon Matthew Chu [République populaire de Chine] ; Siu-Hong Chan [République populaire de Chine] ; Sau-Na Tsai [République populaire de Chine] ; Yi Wang [République populaire de Chine] ; Christopher Hon-Ki Cheng [République populaire de Chine] ; Kam-Bo Wong [République populaire de Chine] ; Mary Miu-Yee Waye [République populaire de Chine] ; Sai-Ming Ngai [République populaire de Chine, Hong Kong]	Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS‐CoV): In search of potent SARS‐CoV entry inhibitors
000207 (2003)	Kate Ramsayer	This won't hurt …: Tiny needles deliver drugs painlessly
000249 (2004)	John Oxford [Royaume-Uni] ; Shobana Balasingam [Royaume-Uni] ; Rob Lambkin [Royaume-Uni]	A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community
000283 (2008)	Mark Bartlam ; Xiaoyu Xue ; Zihe Rao	The search for a structural basis for therapeutic intervention against the SARS coronavirus
000364 (2008)	Tom Jefferson [Italie] ; Ruth Foxlee [Royaume-Uni] ; Chris Del Mar [Australie] ; Liz Dooley [Australie] ; Eliana Ferroni [Italie] ; Bill Hewak [Australie] ; Adi Prabhala [Australie] ; Sreekumaran Nair [Inde] ; Alessandro Rivetti [Italie]	Cochrane Review: Interventions for the interruption or reduction of the spread of respiratory viruses
000369 (2008)	David S. C. Hui [Hong Kong]	Influenza A/H5N1 infection: Other treatment options and issues
000438 (2003)	Walter Hampl [États-Unis] ; T. Mertens [États-Unis]	Virale Atemwegsinfektionen bei Erwachsenen
000534 (2006)	David A. Bradt [États-Unis] ; Christina M. Drummond [Australie]	Avian influenza pandemic threat and health systems response
000571 (2004)	Julia Magden [Finlande] ; Leevi K Ri Inen [Finlande] ; Tero Ahola [Finlande]	Inhibitors of virus replication: recent developments and prospects
000598 (2007)	Landis Mackellar [Autriche]	Pandemic Influenza: A Review
000770 (2010)	Bruce L. Taylor [Royaume-Uni] ; Hugh E. Montgomery [Royaume-Uni] ; Andrew Rhodes [Royaume-Uni] ; Charles L. Sprung [Israël]	Chapter 6. Protection of patients and staff during a pandemic
000884 (2006)	Leonard A. Valentino [États-Unis] ; Veeral M. Oza [États-Unis]	Blood safety and the choice of anti‐hemophilic factor concentrate
000B35 (2011)	Stephan Ludwig [Allemagne]	Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections
000B49 (2010)	Martin Michaelis [Allemagne] ; Janina Geiler [Allemagne] ; Patrizia Naczk [Allemagne] ; Patchima Sithisarn [Allemagne] ; Henry Ogbomo [Allemagne] ; Behric Altenbrandt [Allemagne] ; Anke Leutz [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; Jindrich Cinatl Jr. [Allemagne]	Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages
000D97 (2006)	Ming H. Zheng [Australie] ; Richard Pembrey [Australie] ; Silvana Niutta [Australie] ; Patricia Stewart-Richardson [Australie] ; Albert Farrugia [Australie]	CHALLENGES IN THE EVALUATION OF SAFETY AND EFFICACY OF HUMAN TISSUE AND CELL BASED PRODUCTS
000E82 (2008)	Irene M. Lagoja [Belgique] ; Erik De Clercq [Belgique]	Anti‐influenza virus agents: Synthesis and mode of action
000F02 (2005)	S. Alban [Allemagne]	The ‘precautionary principle’ as a guide for future drug development
001205 (2008)	Ying Zhu [États-Unis] ; Jay W. Warrick [États-Unis] ; Kathryn Haubert [États-Unis] ; David J. Beebe [États-Unis] ; John Yin [États-Unis]	Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays
001220 (2007)	Juliane Mayr [Autriche] ; Thomas Haselhorst [Australie] ; Martijn A. Langereis [Pays-Bas] ; Jeffrey C. Dyason [Australie] ; Wolfgang Huber [Autriche] ; Barbara Frey [Australie] ; Reinhard Vlasak [Autriche] ; Raoul J. De Groot [Pays-Bas] ; Mark Von Itzstein [Australie]	Influenza C virus and bovine coronavirus esterase reveal a similar catalytic mechanism: new insights for drug discovery
001305 (2006)	Marcello Basili [Italie] ; Maurizio Franzini	Understanding the Risk of an Avian Flu Pandemic: Rational Waiting or Precautionary Failure?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "drugs" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "drugs" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    drugs
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021